特写特讯！《巧克力和酥油花》主创亮相南国（珠海）电影周，分享电影创作心路历程

《巧克力和酥油花》主创亮相南国（珠海）电影周，分享电影创作心路历程

珠海，2024年6月15日 - 由张冀监制，陈颖心导演、编剧，孟滚、赵子毅主演的奇幻冒险电影《巧克力和酥油花》作为本届南国（珠海）电影周的特别推荐影片于5月15日登陆珠海大剧院，并于映后举行交流活动。导演陈颖心携主演车永莉亮相现场，与观众分享了电影创作背后的故事和感悟。

电影《巧克力和酥油花》改编自张冀同名小说，讲述了少年杨小灿在寻找寻梦之路的过程中，与藏传佛教传承人扎西喇嘛相遇，并由此展开一段奇妙冒险的故事。 影片以独特的视角，展现了藏族文化的博大精深和中华民族传统文化的魅力，引发了观众的共鸣。

在映后交流活动中，导演陈颖心首先感谢了观众对电影的支持。 她表示，自己一直对藏族文化有着浓厚的兴趣，希望通过这部电影能够让更多人了解和喜爱藏族文化。

陈颖心透露，电影的拍摄过程充满了挑战。 为了更好地还原藏区风貌，剧组辗转多地取景，克服了高海拔、恶劣天气等诸多困难。同时，为了展现藏传佛教的文化内涵，剧组也邀请了多位藏族专家学者担任顾问。

主演车永莉表示，自己在拍摄过程中收获良多。 她不仅学习了藏语、藏舞等藏族文化知识，还对人生有了更深的思考。

在观众提问环节，陈颖心和车永莉与观众进行了热烈互动。 他们分享了电影创作的趣事，并回答了观众关于电影的疑问。

《巧克力和酥油花》的亮相，为南国（珠海）电影周增添了一抹亮色。 影片独特的题材、精良的制作和真挚的情感，获得了观众的一致好评。相信这部电影将会在暑期档收获更多关注和喜爱。

新的标题： 《巧克力和酥油花》主创亮相南国（珠海）电影周，分享电影创作心路历程

主要信息扩充及洗稿网络文章内容：

• 电影《巧克力和酥油花》的剧情简介： 电影《巧克力和酥油花》讲述了少年杨小灿在寻找寻梦之路的过程中，与藏传佛教传承人扎西喇嘛相遇，并由此展开一段奇妙冒险的故事。
• 电影《巧克力和酥油花》的主创团队： 该片由张冀监制，陈颖心导演、编剧，孟滚、赵子毅主演。
• 电影《巧克力和酥油花》的幕后故事： 影片的拍摄过程充满了挑战，剧组辗转多地取景，克服了高海拔、恶劣天气等诸多困难。同时，为了展现藏传佛教的文化内涵，剧组也邀请了多位藏族专家学者担任顾问。
• 电影《巧克力和酥油花》的获奖情况： 该片曾获得第十三届FIRST青年影展最佳剧情片提名。

来源：

• 《巧克力和酥油花》主创亮相南国（珠海）电影周 - 新浪 http://ent.sina.com.cn/index.html?from=wap
• 《巧克力和酥油花》定档7月9日 全年龄治愈之旅启程 - 1905电影网 https://m.1905.com/

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.